187 related articles for article (PubMed ID: 33373589)
21. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
[TBL] [Abstract][Full Text] [Related]
22. The need for immunotherapy when neoadjuvant chemoradiotherapy achieves pathologic complete response in stage IIIB non-small cell lung cancer: a case report.
Lv C; Zhao L; Zhu Y; Wang P; Sun Z
Ann Palliat Med; 2021 Apr; 10(4):4965-4969. PubMed ID: 33966430
[TBL] [Abstract][Full Text] [Related]
23. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
[TBL] [Abstract][Full Text] [Related]
24. Durvalumab Immunotherapy: Nursing Management of Immune-Related Adverse Events During the Journey of Patients With Stage III Non-Small Cell Lung Cancer.
Davies M; Duffield E
Clin J Oncol Nurs; 2020 Jun; 24(3):277-283. PubMed ID: 32441679
[TBL] [Abstract][Full Text] [Related]
25. Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report.
Nishino K; Kunimasa K; Kimura M; Inoue T; Tamiya M; Kuhara H; Kumagai T
BMC Pharmacol Toxicol; 2020 Apr; 21(1):26. PubMed ID: 32245391
[TBL] [Abstract][Full Text] [Related]
26. Bronchoplastic Procedure Versus Pneumonectomy After High-dose Radiation for Non-small Cell Lung Cancer.
Watanabe Y; Suzuki K; Hattori A; Fukui M; Matsunaga T; Oh S; Takamochi K
Ann Thorac Surg; 2021 Dec; 112(6):1832-1840. PubMed ID: 33359721
[TBL] [Abstract][Full Text] [Related]
27. Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer.
Cheema PK; Rothenstein J; Melosky B; Brade A; Hirsh V
Curr Oncol; 2019 Feb; 26(1):37-42. PubMed ID: 30853796
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
[TBL] [Abstract][Full Text] [Related]
29. [When Should We Perform Surgery for N2 Lung Cancer?;Induction Chemoradiotherapy or Surgery for Local Recurrence or Residual Tumor after Definitive Chemoradiotherapy].
Ito H; Nakayama H
Kyobu Geka; 2018 Apr; 71(4):290-299. PubMed ID: 29755103
[TBL] [Abstract][Full Text] [Related]
30. Real-world outcomes of chemoradiotherapy for unresectable Stage III non-small cell lung cancer: The SOLUTION study.
Horinouchi H; Atagi S; Oizumi S; Ohashi K; Kato T; Kozuki T; Seike M; Sone T; Sobue T; Tokito T; Harada H; Maeda T; Mio T; Shirosaka I; Hattori K; Shin E; Murakami H
Cancer Med; 2020 Sep; 9(18):6597-6608. PubMed ID: 32730697
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.
Miura Y; Mouri A; Kaira K; Yamaguchi O; Shiono A; Hashimoto K; Nishihara F; Shinomiya S; Akagami T; Murayama Y; Abe T; Noda SE; Kato S; Kobayashi K; Kagamu H
Thorac Cancer; 2020 May; 11(5):1280-1287. PubMed ID: 32160383
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary resection after chemoradiotherapy for advanced non-small cell lung cancer: the impact of presurgical radiation therapy.
Shiraishi T; Hiratsuka M; Yanagisawa J; Miyahara S; Yoshida Y; Makimoto Y; Hamatake D; Yamashita S; Iwasaki A
Surg Today; 2014 Jan; 44(1):123-30. PubMed ID: 23420096
[TBL] [Abstract][Full Text] [Related]
34. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
35. [Salvage Surgery for Residual and Recurred Tumor after Definitive Chemoradiotherapy].
Ito H; Nakayama H
Kyobu Geka; 2017 Oct; 70(11):915-920. PubMed ID: 29038403
[TBL] [Abstract][Full Text] [Related]
36. Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers.
Misumi K; Harada H; Tsubokawa N; Tsutani Y; Matsumoto K; Miyata Y; Yamashita Y; Okada M
Gen Thorac Cardiovasc Surg; 2017 Jul; 65(7):392-399. PubMed ID: 28432576
[TBL] [Abstract][Full Text] [Related]
37. Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.
Ko JJ; Banerji S; Blais N; Brade A; Clelland C; Schellenberg D; Snow S; Wheatley-Price P; Yuan R; Melosky B
Curr Oncol; 2023 Mar; 30(4):3817-3828. PubMed ID: 37185402
[TBL] [Abstract][Full Text] [Related]
38. Significance of
Kim E; Wu HG; Keam B; Kim TM; Kim DW; Paeng JC; Kim HJ; Chang JH
Clin Lung Cancer; 2019 Jan; 20(1):e9-e23. PubMed ID: 30266585
[TBL] [Abstract][Full Text] [Related]
39. Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
Joosten PJM; Dickhoff C; van der Noort V; Klomp HM; van Diessen JNA; Dahele M; Bahce I; Veenhof AAFA; Smit EF; Hartemink KJ
Lung Cancer; 2020 Dec; 150():209-215. PubMed ID: 33220611
[TBL] [Abstract][Full Text] [Related]
40. Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report.
Zhang T; Wu Y; Zheng S; Cheng G; He X; Bi N
Ann Palliat Med; 2020 Jul; 9(4):2375-2380. PubMed ID: 32692219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
